San Francisco Equity Partners bets on the boring bits

A bottle of Method soap is a small triumph of persuasion: something once hidden beneath a sink becomes something you leave beside it. But the less visible part of Method’s story concerns arithmetic. During the recession, its product assortment had become a problem. Management cut the range from 300 items to 100. By 2010, former CFO Andrea Freedman later reported, the changes had added ten points of gross margin.

The bottle is the easy part

San Francisco Equity Partners backed Method before its 2012 sale to Ecover. The episode supplies a useful introduction to a consumer investor: a product can be desirable while the business making it becomes unwieldy. More varieties mean more things to forecast, produce, and keep in stock. Revenue alone will not tell you whether the collection makes sense.

“It was a tough, tough year.”

Andrea Freedman / former Method CFO

The response came from Method’s management; it should not be recast as a solo rescue by its investor. At the eventual exit, co-founder Eric Ryan credited SFEP with help across distribution, margins, brand strategy, and management development. Those are separate jobs. A prettier bottle cannot perform all of them.

The sale also required a decision about people. Freedman described investors wanting a route to liquidity after the recession, alongside management’s concern about a buyer’s treatment of Method’s culture. Ecover offered a compatible set of values. The company examined other buyers, internal liquidity, and remaining independent before choosing the combination. An exit price is only one part of an exit.

A drinkware deal with a deodorant connection

SFEP, founded by Scott Potter in 2005, works in the lower middle market. Its published criteria describe companies with $15–$100+ million in revenue and $3–$15+ million in EBITDA, a measure of operating earnings before interest, taxes, depreciation, and amortization. It takes control or significant minority stakes. This is capital for a business with an operating history.

Consider BrüMate. In September 2020, SFEP announced a $20 million strategic investment, the drinkware company’s first outside funding. Founder Dylan Jacob had already built an audience for insulated containers. The announcement described more than two million customers worldwide. SFEP was entering after people had demonstrated that they wanted the product.

The intriguing participant was Moiz Ali, founder of natural deodorant brand Native. He invested alongside SFEP and was to work with Jacob’s team on digital marketing and ecommerce. Deodorant and drinkware occupy different shelves. Acquiring customers online gives their founders something to discuss. For an owner evaluating capital, that is a practical question: which relevant problems has the proposed partner already worked through?

Follow the work behind the label

The portfolio gets more interesting when the famous labels recede. In January 2021, SFEP acquired Smith & Vandiver Corporation, known as SV Labs. The business manufactured natural beauty and personal care products, including bath bombs and shower tablets, and supplied formulation, filling, packaging, and fulfillment services. Its customers included emerging brands, larger consumer companies, and retailers.

In February 2025 came a majority investment in Formula Corp, a cleaning-products formulator and contract manufacturer. Co-founders Chas Werner and Alan Gangl remained shareholders. The company’s work stretches from research and blending to labeling and regulatory support. The announcement called it SFEP’s fifth specialty-manufacturing platform investment. Buying a factory’s capabilities is another way to participate in consumer demand.

That breadth is distinctive within SFEP’s story, although it is not exclusive territory. Fellow consumer investor Encore also backs brands, manufacturers, and distributors. The useful comparison is specific experience, ownership terms, and who will actually help management. A general promise of partnership settles very little.

For a brand owner, the manufacturing examples are instructive. Formula Corp describes flexible batch sizes, in-house development, and support for scaling production. Those services address different stages of a product’s life. A workable laboratory formula still has to become a repeatable commercial batch. A retailer’s new order still has to arrive. The investment thesis becomes easier to understand when you follow those ordinary tasks.

Buying the route to the customer

Xceed Foodservice Group sells no snack you can put in a shopping basket. It provides sales and marketing services to food suppliers through regional brokerages. Established in 2024, the SFEP-backed platform announced its eleventh investment in April 2026: Encore Food Solutions, extending coverage into Texas and Oklahoma. Encore’s management stayed in place and retained equity in Xceed.

Agility Retail Group tackles another unglamorous necessity: fixtures, displays, signage, and store environments. Its June 2026 purchase of Texas-based Marco was its fifth acquisition with SFEP. Marco’s grocery-department expertise added manufacturing capabilities. The logic is visible: help a supplier serve more of a retailer’s requirements. Execution still depends on fitting the acquired operations together.

A useful question before the next launch

SFEP’s business is ownership: invest, help build value, and ultimately realize that investment. The $20 million BrüMate announcement was capital going into a portfolio company. It was neither SFEP’s fundraising round nor an advertised service fee. Founders considering such a partner are negotiating an ownership relationship, with decisions about control and future liquidity attached.

The transferable lesson is to identify what growth is asking the business to do. Audit product complexity. Find the constraint in manufacturing or distribution. Ask whether another acquisition adds a capability customers need. This approach assumes established demand and a team willing to share decisions; a pre-revenue idea or a founder seeking passive capital is a different proposition. Before the next launch, Method’s history suggests one useful question: what would happen if the product list got shorter?